On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Cancer Research Institute of the Slovak Academy of Sciences

InstitutionResearch output, impact & collaborations

Cancer Research Institute of the Slovak Academy of Sciences is a institution indexed in ScholarIQ from OpenAlex.

What is known about Cancer Research Institute of the Slovak Academy of Sciences?

ScholarIQrecord summary

Cancer Research Institute of the Slovak Academy of Sciences is a research organisation in Bratislava, SK. OpenAlex records 2,393 works and 344,888 citations for it. 571 researchers list it as their most recent affiliation.

How many works does Cancer Research Institute of the Slovak Academy of Sciences have?

ScholarIQindexed works

Cancer Research Institute of the Slovak Academy of Sciences has 2,393 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Cancer Research Institute of the Slovak Academy of Sciences →

How many citations does Cancer Research Institute of the Slovak Academy of Sciences have?

ScholarIQcitation count

Cancer Research Institute of the Slovak Academy of Sciences has 344,888 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Cancer Research Institute of the Slovak Academy of Sciences →

How many researchers are at Cancer Research Institute of the Slovak Academy of Sciences?

ScholarIQresearcher count

Cancer Research Institute of the Slovak Academy of Sciences has 571 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Cancer Research Institute of the Slovak Academy of Sciences?

ScholarIQavg h-index

Cancer Research Institute of the Slovak Academy of Sciences has an average h-index of 61.2 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Cancer Research Institute of the Slovak Academy of Sciences?

ScholarIQror

The ROR for Cancer Research Institute of the Slovak Academy of Sciences is on the source record.

Open the ROR →

What is the OpenAlex record for Cancer Research Institute of the Slovak Academy of Sciences?

ScholarIQopenalex

The OpenAlex for Cancer Research Institute of the Slovak Academy of Sciences is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Cancer Research Institute of the Slovak Academy of Sciences?

ScholarIQtop researchers by citations

Michael A. Hollingsworth · Pancreatic and Hepatic Oncology Research

890 works54,474 citations

Christina Peters · Hematopoietic Stem Cell Transplantation

441 works24,639 citations

Peter F. Ambros · Neuroblastoma Research and Treatments

373 works22,917 citations

Luiz O. Penalva · Genomics and Chromatin Dynamics

1 works19,576 citations

Samuel Waxman · Retinoids in leukemia and cellular processes

278 works17,524 citations

What are the most-cited papers on Cancer Research Institute of the Slovak Academy of Sciences?

ScholarIQmost cited works

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner, Susana Rives, Michael Boyer, Henrique Bittencourt, Peter Bader, Michael R. Verneris, Heather E. Stefanski, Gary D. Myers, Muna Qayed, Barbara De Moerloose, Hidefumi Hiramatsu, Krysta Schlis, Kara L. Davis, Paul L. Martin, Eneida R. Nemecek, Gregory A. Yanik, Christina Peters, André Baruchel, Nicolas Boissel, Françoise Méchinaud, Adriana Balduzzi, Joerg Krueger, Carl H. June, Bruce L. Levine, Patricia A. Wood, Tetiana Taran, Mimi Leung, Karen T. Mueller, Yiyun Zhang, Kapildeb Sen, David Lebwohl, Michael A. Pulsipher, Stephan A. Grupp

New England Journal of Medicine. 20185,720 CitationsOPEN ACCESS

The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

Susan L. Cohn, Andrew D.J. Pearson, Wendy B. London, Tom Monclair, Peter F. Ambros, Garrett M. Brodeur, Andreas Faldum, Barbara Hero, Tomoko Iehara, David Machin, Véronique Mosseri, Thorsten Simon, Alberto Garaventa, Victoria Castel, Katherine K. Matthay

Journal of Clinical Oncology. 20081,919 Citations

Long-term efficacy and safety of <i>all-trans</i> retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia

Jiong Hu, Yuan-Fang Liu, Chuan-Feng Wu, Fang Xu, Zhi-Xiang Shen, Yong-Mei Zhu, Junmin Li, Wei Tang, Weili Zhao, Wen Wu, Hui-Ping Sun, Qiu-Sheng Chen, Bing Chen, Guang‐Biao Zhou, Arthur Zelent, Samuel Waxman, Zhen-Yi Wang, Sai-Juan Chen, Zhu Chen

Proceedings of the National Academy of Sciences. 2009438 Citations

Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial

Selim Corbacioglu, Simone Cesaro, Maura Faraci, Dominique Valteau‐Couanet, Bernd Gruhn, Attilio Rovelli, Jaap Jan Boelens, Annette Hewitt, Johanna Schrum, Ansgar Schulz, Ingo Müller, Jerry Stein, Robert Wynn, Johann Greil, Karl-Walter Sykora, Susanne Matthes‐Martin, Monika Führer, Anne O’Meara, Jacek Toporski, Petr Sedláček, Paul G. Schlegel, Karoline Ehlert, Anders Fasth, Jacek Winiarski, Johan Arvidson, Christine Mauz‐Körholz, Hulya Ozsahin, André Schrauder, Peter Bader, Joseph M. Massaro, Ralph B. D’Agostino, Margaret Hoyle, Massimo Iacobelli, Klaus‐Michael Debatin, Christina Peters, Giorgio Dini

The Lancet. 2012376 Citations

Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial

Theodore W. Laetsch, Shannon L. Maude, Susana Rives, Hidefumi Hiramatsu, Henrique Bittencourt, Peter Bader, André Baruchel, Michael Boyer, Barbara De Moerloose, Muna Qayed, Jochen Buechner, Michael A. Pulsipher, Gary Douglas Myers, Heather E. Stefanski, Paul L. Martin, Eneida R. Nemecek, Christina Peters, Gregory A. Yanik, Seong Lin Khaw, Kara L. Davis, Joerg Krueger, Adriana Balduzzi, Nicolas Boissel, Ranjan Tiwari, Darragh O’Donovan, Stephan A. Grupp

Journal of Clinical Oncology. 2022366 CitationsOPEN ACCESS

How much of the research on Cancer Research Institute of the Slovak Academy of Sciences is open access?

ScholarIQopen access share

50%OPEN ACCESS

Gold

Green

Hybrid

30%

Bronze

20%

Closed

50%